As a recognition of our scientific capabilities, Amgen UK has won a number of awards including Best New Drug at the Scrip Awards in 2009 and 2010 for Nplate® (romiplostim) and Prolia® (denosumab) respectively, as well as Best Overall Pipeline at the Scrip Awards in 2009.

Amgen UK has been named one of The Sunday Times’ Top 100 “Best Companies to Work For” in both 2008 and 2009.